Skip to main content

Diabetes Mellitus and Hyperlipidemias

  • Chapter
The Genetics of Diabetes Mellitus
  • 199 Accesses

Abstract

The one generally accepted definition of diabetes mellitus is hyperglycemia inappropriate to the existing environmental and nutritional state. However, this symptom is only one of many endocrine and metabolic alterations present inclinically overtdiabetes, among which disturbances in lipid metabolism are most important. Perhaps the oldest notion of the associated appearance of diabetes mellitus and hyperlipemia is, according to a quotation by Eggstein, a statement of Marietin 1799 (22), and in 1917 Joslin (18) stated: “with an excess of fat diabetes begins and from anexcess of fat diabetics die.” In the earlier part of this century most authors apparently agreed that the extent of hyperlipemia depended largely on the severity of active diabetic symptoms and that the blood-lipid concentration represented the most reliable prognostic criterion for the diabetic patient (6,18). This was contradicted, however, by several authors and in Germany among others by Katsch (19), who in 1938 expressed the view that the extent of disturbance of lipid metabolism was not generally related to the severity of diabetes, although in the mean blood lipids tended to rise with acute diabetic decompensation and to fall again with recompensation. The moderately to strongly elevated blood-lipid concentration in well-adjusted diabetics was judged by him torepresent a personal characteristic of the individual patient. Katsch and Krainick (19) already distinguished the reversible hyperlipemia accompanying the acute diabetic decompensation from the irreversible, permanent hyperlipemia of well-adjusted diabetics. In 1955 Adlersberg and Wang (1) delineated the combined appearance of mild diabetes mellitus and severe idiopathic hyperlipemia as a distinct syndrome, which has previously been noted by Thannhauser (36) and therefore is referred to by some as the Thannhauser-Adlersberg or Adlersberg-Wang syndrome and by others as the “diabetic-hyperlipemic syndrome”(23).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adlersberg, D., Wang, C.: Syndrome of idiopathic hyperlipemia, mild diabetes mellitus, and severe vascular damage. Diabetes 4, 210 (1955)

    PubMed  CAS  Google Scholar 

  2. Adlersberg, D., Eisler, L.: Circulating lipids in diabetes mellitus. JAMA 170, 1261 (1959)

    Article  CAS  Google Scholar 

  3. Albrink, M.J., Lavietes, P.H., Man, E.B.: Vascular disease and serum lipids in diabetes mellitus. Observations over 30 years (1931-1961). Ann. Int. Med. 58, 305 (1963)

    PubMed  CAS  Google Scholar 

  4. Bergqvist, N.: Serum lipids in an ambulatory diabetic clientele. Acta med. scand. 187, 213 (1970)

    Article  PubMed  CAS  Google Scholar 

  5. Bierman, E.L., Porte, D.: Carbohydrate intolerance and lipemia. Ann. Int. Med. 68, 926 (1968)

    PubMed  CAS  Google Scholar 

  6. Bloor, W.R.: The lipoids (“fat”) of the blood in diabetes. Journ. Biol. Chem. 26, 417 (1916)

    CAS  Google Scholar 

  7. Borrie, P., Slack, J.: A clinical syndrome characteristic of primary type IV-V hyperlipoproteinemia. Brit. Journ. Dermatology 90, 245 (1974)

    Article  CAS  Google Scholar 

  8. Braunsteiner, H., Sailer, S., Sandhofer, F.: Plasmalipide bei Patiefoten mit Diabetes mellitus. Klin. Wschr. 44, 116 (1966)

    Article  PubMed  CAS  Google Scholar 

  9. Brown, D.F., Daudiss, K.: Hyperlipoproteinemia. Prevalence in a free-living population in Albany, New York. Circulation XLVII, 558 (1973)

    Article  Google Scholar 

  10. Chance, G.W., Albutt, E.C., Edkins, S.M.: Serum lipids and lipoproteins in untreated diabetic children. Lancet I, 1126 (1969)

    Article  Google Scholar 

  11. Eaton, R.P., Schade, D.S.: Glucagon resistance as a hormonal basis for endogenous hyperlipemia. Lancet I, 973 (1973)

    Article  Google Scholar 

  12. Ford, S., Bozian, R.C., Knowles, H.C.: Interactions of obesity, and glucose and insulin levels in hypertriglyceridemia. Amer. Journ. Clin. Invest. 21, 904 (1968)

    Google Scholar 

  13. Glueck, C.J., Levy, R.I., Fredrickson, D.S.: Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, II, IV, and V hyperlipo-proteinemia. Diabetes 18, 739 (1969)

    PubMed  CAS  Google Scholar 

  14. Gries, F.A., Engelhardt, A., Cramer, M., Jahnke, K.: Metabolite des Fett-und Kohlenhydratstoffwechsels bei normgewichtigen Stoffwechselgesunden sowie bei Adipösen und Diabetikern. Verhandl. Deutsch. Ges. Inn. Med. 76, 371 (1970)

    Google Scholar 

  15. Fredrickson, D.S., Levy, R.: Familial hyperlipoproteinemia. In: The Metabolic Basis of Inherited Disease, 3rd ed. Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S. (eds.). New York: McGraw Hill, 1972

    Google Scholar 

  16. Jacobsen, B.B.: Type Vhyperlipoproteinemia. Atherosclerosis 17, 471 (1973)

    Article  PubMed  CAS  Google Scholar 

  17. Jahnke, K.: Störungen des Fettstoffwechsels. Ärztl. Praxis 26,4438 (1974)

    Google Scholar 

  18. Joslin, E.P., Bloor, W.R., Gray, H.: The blood lipoids in diabetes. Journ. Amer. Med. Ass. 69, 375 (1917)

    Article  CAS  Google Scholar 

  19. Katsch, G., Krainick, H.G.: Zur Physiologie und Pathologie des intermediären Fettstoffwechsels. Klin. Wschr. 18, 436 (1939)

    Article  Google Scholar 

  20. Levy, R.I., Glueck, C.J.: Hypertriglyceridemia, diabetes mellitus, and coronary vessel disease. Arch. Intern. Med., 123, 220 (1969)

    Article  PubMed  CAS  Google Scholar 

  21. Man, E.B., Albrink, M.J.: Serum lipids in different phases of carbohydrate metabolism. Yale J. Biol. Med. 29, 316 (1956)

    PubMed  CAS  Google Scholar 

  22. Mariet (1799). Cited by M. Eggstein: Diabetes und Fett. Med. Welt 18, 843 (1967)

    Google Scholar 

  23. Nikkilä, E.A.: Plasma triglycerides in human diabetes. Proc. Royal Soc. Med. 67, 662 (1974)

    Google Scholar 

  24. Nikkila, E.A.: Control of plasma and liver triglyceride kinetics by carbohydrate metabolism and insulin. Advances Lipid. Res. 7, 63 (1969)

    CAS  Google Scholar 

  25. Olefsky, J.M., Farquhar, J.W., Reaven, G.M.: Reappraisal of the role of insulin in hypertriglyceridemia. Amer. Journ. Med. 57, 551 (1974)

    Article  CAS  Google Scholar 

  26. Reaven, G.M., Lerner, R.L., Stern, M.P., Farquhar, J.W., Nakanishi, R.: Role of insulin in endogenous hypertriglyceridemia. Journ. Clin. Invest. 46, 1756 (1967)

    Article  CAS  Google Scholar 

  27. Reimer, F., Kremer, G.J., Müller, D.: Häufigkeit von Fettstoffwechselstörungen bei asymptomatischen und manifesten Diabetikern. Klin. Wschr. 51, 973 (1973)

    Article  PubMed  CAS  Google Scholar 

  28. Rose, H.G., Kranz, P., Weinstock, M., Juliano, J., Haft, J.I.: Combined hyperlipoproteinemia. Evidence for a new lipoprotein phenotype. Atherosclerosis 20, 51 (1974)

    Article  PubMed  CAS  Google Scholar 

  29. Righetti, A., Scherrer, J.R., Micheli, H., Pometta, D.: Etude clinique des relations entre lediabète, les hyperlipoprotéinémies et l’athéromatose. Schweiz. med. Wschr. 103, 668 (1973)

    PubMed  CAS  Google Scholar 

  30. Saddi, R., Feingold, J.: Idiopathic hemochromatosis and diabetes mellitus. Clin. Genet. 5., 242 (1974)

    Article  PubMed  CAS  Google Scholar 

  31. Sailer, S., Bolzano, K., Sandhofer, F., Spath, P., Braunsteiner, H.: Triglyceridspiegel und Insulinkonzentration im Plasma nach oraler Glukosegabe bei Patienten mit primärer kohlenhydratinduzierter Hypertriglyceridamie. Schweiz. Med. Wschr. 98, 1512 (1968)

    PubMed  CAS  Google Scholar 

  32. Santen, R.J., Willis, P.W., Fajans, S.S.: Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level. Arch. Intern. Med. 130, 833 (1972)

    Article  PubMed  CAS  Google Scholar 

  33. Schlierf, G., Weinans, G., Weinans, T., Reinheimer, W., Kahlke, W.: Häufigkeit und Typenverteilung von Hyperlipoproteinämien bei stationären Patienten einer Medizinischen Klinik. Dtsch. Med. Wschr. 97, 1371 (1972)

    Article  PubMed  CAS  Google Scholar 

  34. Schonfeld, G., Kudzma, D.J.: Type IV hyperlipoproteinemia, acritical appraisal. Arch. Intern. Med. 132, 55 (1973)

    Article  PubMed  CAS  Google Scholar 

  35. Schonfeld, G., Birge, C., Miller, P., Kessler, G., Santiago, J.: Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes 23, 827 (1974)

    PubMed  CAS  Google Scholar 

  36. Thannhauser, S.J.: lew Engl. J. Med. 237, 515 (1947). Cited by Nikkilä, 1974

    Article  CAS  Google Scholar 

  37. Tiengo, A., Muggeo, M., Fedele, D., Marchior, E., Crepaldi, G.: Insulin-secretion in hyperlipoproteinemias. Act. Diabet. 11, 149 (1974)

    Article  Google Scholar 

  38. Tzagournis, M., Chiles, R., Ryan, J.M., Skillman, T.G.: Interrelatioships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease. Circulation 38, 1156 (1968)

    Article  PubMed  CAS  Google Scholar 

  39. Vogelberg, K.H., Gries, F.A.: Hyperlipoproteinamie bei Diabetes Mellitus. Münchn. Med. Wschr. 115, 650 (1973)

    Google Scholar 

  40. Wahl, P., Hasslacher, Ch., Vollmar, J.: Diabetes und Hyperlipoproteinämien. Dtsch. Med. Wschr. 99, 2158 (1974)

    Article  PubMed  CAS  Google Scholar 

  41. Wille, L.E., Aarseth, S.: Demonstration of hyper-x-lipoproteinemia in three diabetic patients. Clin. Genet. 4, 281(1973)

    Article  PubMed  CAS  Google Scholar 

  42. Wilson, D.E., Schreibman, P.H., Day, V.C., Arky, R.A.: Hyperlipidemia in an adult diabetic population. J. Chron. Dis. 23, 501 (1970)

    Article  Google Scholar 

  43. Wood, P.D.S., Stern, M.P., Silvers, A., Reaven, G.M., Groeben, J. von der: Prevalence of plasma lipoprotein abnormalities in a free-living population of the Central valley, California. Circulation XLV, 114 (1972)

    Article  Google Scholar 

  44. Wollenweber, J., Christl, H.L., Schlierf, Chr., Wohlenberg, H.: Hyperlipoproteinämien bei ambulanten Patienten. Dtsch. Med. Wschr. 98, 463 (1973)

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fuhrmann, W. (1976). Diabetes Mellitus and Hyperlipidemias. In: Creutzfeldt, W., Köbberling, J., Neel, J.V. (eds) The Genetics of Diabetes Mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66332-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66332-1_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-07651-3

  • Online ISBN: 978-3-642-66332-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics